141 filings
Page 5 of 8
8-K
k2n38d um0
27 Sep 17
Preliminary data from ASPIRO expected to be available in the fourth quarter of 2017
12:00am
EFFECT
sr5cw9rl6c309 p6c
23 Aug 17
Notice of effectiveness
12:00am
CORRESP
oco9hcioi
22 Aug 17
Correspondence with SEC
12:00am
CT ORDER
53ojfcd
22 Aug 17
Confidential treatment order
12:00am
8-K
m0gk3kruoao9rrr z3o1
10 Aug 17
Audentes Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update
12:00am
S-3
py1c57y3
8 Aug 17
Shelf registration
12:00am
8-K
djz6hr3p
14 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
dcxkue
13 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
gcg0z
7 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
t8lmr
11 May 17
Results of Operations and Financial Condition
12:00am
8-K
vb406f0
5 May 17
Departure of Directors or Certain Officers
12:00am
DEFA14A
vg1c04x
27 Apr 17
Additional proxy soliciting materials
12:00am
DEF 14A
pl6h4r8e
27 Apr 17
Definitive proxy
12:00am
424B4
ring sp5i
19 Apr 17
Prospectus supplement with pricing info
12:00am
S-1MEF
hnvonziz1t
18 Apr 17
Registration of additional securities for an S-1
12:00am
EFFECT
lnpemi5f mei
18 Apr 17
Notice of effectiveness
12:00am
CORRESP
aznr7a4f 9t7n
17 Apr 17
Correspondence with SEC
12:00am